---
figid: PMC9412302__pharmaceuticals-15-01027-g008
pmcid: PMC9412302
image_filename: pharmaceuticals-15-01027-g008.jpg
figure_link: /pmc/articles/PMC9412302/figure/pharmaceuticals-15-01027-f008/
number: Figure 8
figure_title: ''
caption: 'ASP attenuated the RANKL-induced NF-κB and ERK1/2 signaling pathways activations.
  (A–D) Effects of ASP on NF-κB pathway. (E–H) Effects of ASP on MAPK pathway. n =
  3, ns: no significance, * p < 0.05 and ** p < 0.01.'
article_title: Asperuloside Prevents Peri-Implantitis via Suppression of NF-κB and
  ERK1/2 on Rats.
citation: Xinge Wang, et al. Pharmaceuticals (Basel). 2022 Aug;15(8):1027.
year: '2022'

doi: 10.3390/ph15081027
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI

keywords:
- asperuloside
- peri-implantitis
- osteoclasts
- NF-κB signaling
- ERK1/2 signaling

---
